Investor Relations
Opportunity
Agile Life Sciences is an Enterprise Investment Scheme (EIS) qualifying Life Sciences company based in Flintshire, North Wales.
We are grateful of the support received from the UK Research & Innovation (UKRI) including the following article: www.ukri.org/news/transforming-the-way-menopause-is-diagnosed-monitored-and-managed/
Why Invest?
Ground-breaking, patent protected science
Experienced and motivated team – each with equity (‘skin in the game’)
Large unmet market need for a menopause diagnostic
EIS qualifying (30% tax relief)
Previous Funding
Agile Life Sciences successfully closed a funding round of £200k in August 2022. The funding round comprised “Angel” investors and was led by NorthInvest. This funding was matched by an Innovate UK grant for £200k under the Regional Accelerator Investment Award.
This combined funding of £400k facilitated critical laboratory capital equipment to be purchased and a comprehensive pilot study to be undertaken of 1,000 patients using our novel MenoGuide service, including a bespoke report for each patient.
Click to view the full Case study below in NorthInvest Annual Report.
Interested in Investing?
If you are interested in becoming an investor and benefiting from the 30% tax relief under the EIS scheme, then please fill out the following form and we will be in touch or email the Joint CEO peter.whitehurst@agilelifesciences.com
Phone
Location
Co-Workz, Flintshire
CH1 4QL
Office Hours
Mon - Fri
8am-6pm
Follow Us
Accreditations
Agile Life Sciences has achieved certification to ISO13485 and operates an ISO15189-compliant laboratory quality management system.
